比较基于英国国家医疗服务系统健康检查计划和多药丸预防计划的筛查在心脏病发作和中风初级预防中的作用。

IF 2.6 4区 医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Journal of Medical Screening Pub Date : 2024-06-01 Epub Date: 2024-03-15 DOI:10.1177/09691413241235488
Nicholas J Wald, Aroon D Hingorani, Stephen H Vale, Jonathan P Bestwick, Joan Morris
{"title":"比较基于英国国家医疗服务系统健康检查计划和多药丸预防计划的筛查在心脏病发作和中风初级预防中的作用。","authors":"Nicholas J Wald, Aroon D Hingorani, Stephen H Vale, Jonathan P Bestwick, Joan Morris","doi":"10.1177/09691413241235488","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To compare the NHS Health Check Programme with the Polypill Prevention Programme in the primary prevention of heart attacks and strokes.</p><p><strong>Design: </strong>Use of published data and methodology to produce flow charts of the two programmes to determine screening performance and heart attacks and strokes prevented.</p><p><strong>Setting: </strong>The UK population.</p><p><strong>Intervention: </strong>The NHS Health Check Programme using a QRISK score on people aged 40-74 to select those eligible for a statin is compared with the Polypill Prevention Programme in people aged 50 or more to select people for a combination of a statin and three low-dose blood pressure lowering agents. In both programmes, people had no history of heart attack or stroke.</p><p><strong>Main outcome measures: </strong>In 1000 people, the number of heart attacks and strokes prevented in the two programmes.</p><p><strong>Results: </strong>In the hypothetical perfect situation with 100% uptake and adherence to the screening protocol, in every 1000 persons, the NHS Health Check would prevent 287 cases of a heart attack or stroke in individuals who would gain on average about 4 years of life without a heart attack or stroke amounting to 1148 years in total, the precise gain depending on the extent of treatment for those with raised blood pressure, and 136 would be prescribed statins with no benefit. The corresponding figures for the Polypill Prevention Programme are 316 individuals who would, on average, gain 8 years of life without a heart attack or stroke, amounting to 2528 years in total, and 260 prescribed the polypill with no benefit. Based on published estimates of uptake and adherence in the NHS Health Check Programme, in practice only 24 cases per 1000 are currently benefitting instead of 287, amounting to 96 years gained without a heart attack or stroke.</p><p><strong>Conclusions: </strong>The Polypill Prevention Programme is by design simpler with the potential of preventing many more heart attacks and strokes than the NHS Health Check Programme.</p>","PeriodicalId":51089,"journal":{"name":"Journal of Medical Screening","volume":" ","pages":"59-65"},"PeriodicalIF":2.6000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11083722/pdf/","citationCount":"0","resultStr":"{\"title\":\"Comparing screening based on the NHS Health Check and Polypill Prevention Programmes in the primary prevention of heart attacks and strokes.\",\"authors\":\"Nicholas J Wald, Aroon D Hingorani, Stephen H Vale, Jonathan P Bestwick, Joan Morris\",\"doi\":\"10.1177/09691413241235488\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To compare the NHS Health Check Programme with the Polypill Prevention Programme in the primary prevention of heart attacks and strokes.</p><p><strong>Design: </strong>Use of published data and methodology to produce flow charts of the two programmes to determine screening performance and heart attacks and strokes prevented.</p><p><strong>Setting: </strong>The UK population.</p><p><strong>Intervention: </strong>The NHS Health Check Programme using a QRISK score on people aged 40-74 to select those eligible for a statin is compared with the Polypill Prevention Programme in people aged 50 or more to select people for a combination of a statin and three low-dose blood pressure lowering agents. In both programmes, people had no history of heart attack or stroke.</p><p><strong>Main outcome measures: </strong>In 1000 people, the number of heart attacks and strokes prevented in the two programmes.</p><p><strong>Results: </strong>In the hypothetical perfect situation with 100% uptake and adherence to the screening protocol, in every 1000 persons, the NHS Health Check would prevent 287 cases of a heart attack or stroke in individuals who would gain on average about 4 years of life without a heart attack or stroke amounting to 1148 years in total, the precise gain depending on the extent of treatment for those with raised blood pressure, and 136 would be prescribed statins with no benefit. The corresponding figures for the Polypill Prevention Programme are 316 individuals who would, on average, gain 8 years of life without a heart attack or stroke, amounting to 2528 years in total, and 260 prescribed the polypill with no benefit. Based on published estimates of uptake and adherence in the NHS Health Check Programme, in practice only 24 cases per 1000 are currently benefitting instead of 287, amounting to 96 years gained without a heart attack or stroke.</p><p><strong>Conclusions: </strong>The Polypill Prevention Programme is by design simpler with the potential of preventing many more heart attacks and strokes than the NHS Health Check Programme.</p>\",\"PeriodicalId\":51089,\"journal\":{\"name\":\"Journal of Medical Screening\",\"volume\":\" \",\"pages\":\"59-65\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11083722/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Medical Screening\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/09691413241235488\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/3/15 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Screening","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/09691413241235488","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/15 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

摘要

目的比较英国国家医疗服务系统健康检查计划与多药丸预防计划在心脏病发作和脑卒中一级预防方面的效果:设计:利用已公布的数据和方法制作两个计划的流程图,以确定筛查效果以及心脏病发作和中风的预防率:干预措施干预措施:英国国家医疗服务体系健康检查计划(NHS Health Check Programme)通过对 40-74 岁的人群进行 QRISK 评分来选择符合他汀类药物治疗条件的人群,而多丸类药物预防计划(Polypill Prevention Programme)则通过对 50 岁或以上的人群进行 QRISK 评分来选择他汀类药物和三种低剂量降压药的组合。在这两项计划中,受试者均无心脏病发作或中风史:结果:在假定的完美情况下,两个方案都能预防心脏病发作和中风:结果:在100%接受和遵守筛查方案的完美假设情况下,每1000人中,英国国家医疗服务体系健康检查可预防287例心脏病发作或中风,这些人平均可获得约4年的无心脏病发作或中风寿命,总计1148年,具体收益取决于血压升高者的治疗程度,136人将被处方他汀类药物,但无任何益处。多药丸预防计划的相应数字为:316 人平均可延长 8 年寿命,即总共可延长 2528 年寿命,不会发生心脏病发作或中风;260 人可服用多药丸,但无任何益处。根据已公布的英国国家医疗服务体系健康检查计划的接受率和坚持率估算,实际上,目前每 1000 人中只有 24 人受益,而不是 287 人,即 96 年不会发生心脏病或中风:结论:"多丸预防计划 "在设计上比 "国民保健服务健康检查计划 "更简单,有可能预防更多的心脏病发作和中风。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Comparing screening based on the NHS Health Check and Polypill Prevention Programmes in the primary prevention of heart attacks and strokes.

Objective: To compare the NHS Health Check Programme with the Polypill Prevention Programme in the primary prevention of heart attacks and strokes.

Design: Use of published data and methodology to produce flow charts of the two programmes to determine screening performance and heart attacks and strokes prevented.

Setting: The UK population.

Intervention: The NHS Health Check Programme using a QRISK score on people aged 40-74 to select those eligible for a statin is compared with the Polypill Prevention Programme in people aged 50 or more to select people for a combination of a statin and three low-dose blood pressure lowering agents. In both programmes, people had no history of heart attack or stroke.

Main outcome measures: In 1000 people, the number of heart attacks and strokes prevented in the two programmes.

Results: In the hypothetical perfect situation with 100% uptake and adherence to the screening protocol, in every 1000 persons, the NHS Health Check would prevent 287 cases of a heart attack or stroke in individuals who would gain on average about 4 years of life without a heart attack or stroke amounting to 1148 years in total, the precise gain depending on the extent of treatment for those with raised blood pressure, and 136 would be prescribed statins with no benefit. The corresponding figures for the Polypill Prevention Programme are 316 individuals who would, on average, gain 8 years of life without a heart attack or stroke, amounting to 2528 years in total, and 260 prescribed the polypill with no benefit. Based on published estimates of uptake and adherence in the NHS Health Check Programme, in practice only 24 cases per 1000 are currently benefitting instead of 287, amounting to 96 years gained without a heart attack or stroke.

Conclusions: The Polypill Prevention Programme is by design simpler with the potential of preventing many more heart attacks and strokes than the NHS Health Check Programme.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Medical Screening
Journal of Medical Screening 医学-公共卫生、环境卫生与职业卫生
CiteScore
4.90
自引率
3.40%
发文量
40
审稿时长
>12 weeks
期刊介绍: Journal of Medical Screening, a fully peer reviewed journal, is concerned with all aspects of medical screening, particularly the publication of research that advances screening theory and practice. The journal aims to increase awareness of the principles of screening (quantitative and statistical aspects), screening techniques and procedures and methodologies from all specialties. An essential subscription for physicians, clinicians and academics with an interest in screening, epidemiology and public health.
期刊最新文献
Age-specific differences in tumour characteristics between screen-detected and non-screen-detected breast cancers in women aged 40-74 at diagnosis in Sweden from 2008 to 2017. Association between time to colonoscopy after positive fecal testing and colorectal cancer outcomes in Alberta, Canada. Cancer screening programs in Japan: Progress and challenges. Strong association between reduction of late-stage cancers and reduction of cancer-specific mortality in meta-regression of randomized screening trials across multiple cancer types. Factors associated with private or public breast cancer screening attendance in Queensland, Australia: A retrospective cross-sectional study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1